Novavax Inc

19 de ago. de 2026, 23:51 UTC

Novavax Inc. shares are lower in after-market hours amid broader declines in biotechnology stocks, despite an earlier session peak above Wednesday's close.

17 de ago. de 2026, 19:36 UTC

Novavax Inc is trading higher, reaching a session peak earlier today. The stock remains at the upper end of its one-month trading range.

14 de ago. de 2026, 23:26 UTC

Novavax Inc. shares are trading roughly flat in after-market hours, remaining above the 20-day moving average and near the upper end of the one-month range.

13 de ago. de 2026, 19:16 UTC

Novavax Inc. shares are higher today, maintaining strength above the 20-day moving average despite rising initial jobless claims reported by the Labor Department.

12 de ago. de 2026, 23:31 UTC

Novavax Inc. shares are lower in after-market trading, reflecting a weaker trend despite earlier gains. The stock remains above its 20-day moving average.

11 de ago. de 2026, 23:51 UTC

Novavax Inc. shares are higher in after-market trading, maintaining a position above the 20-day moving average within its one-month trading range.

10 de ago. de 2026, 23:46 UTC

Novavax Inc. shares are lower in after-market trading, showing some volatility since Monday's close and remaining within the middle of their one-month trading range.

7 de ago. de 2026, 19:36 UTC

Novavax Inc shares are higher today, supported by $57 million in second-quarter revenue and ongoing discussions with Sanofi on a COVID-19/influenza vaccine.

6 de ago. de 2026, 23:01 UTC

Novavax Inc expects 2026 revenue of $235 million to $275 million. Shares are trading higher in after-market hours following the earnings call.

5 de ago. de 2026, 23:01 UTC

Novavax shares are higher in after-market trading, though they remain below the 20-day moving average amid weaker-than-expected U.S. job growth data.

4 de ago. de 2026, 23:36 UTC

Novavax Inc. shares are higher in after-market trading, despite remaining below their 20-day moving average. Broader market sentiment may support this upward movement.

3 de ago. de 2026, 23:46 UTC

Novavax Inc is advancing in after-market trading as it shifts focus to licensing its Matrix-M adjuvant, attracting positive retail investor sentiment ahead of earnings.

31 de jul. de 2026, 19:16 UTC

Novavax Inc. shares are lower today, reflecting a decline from Thursday's close amid rising bond yields and crude oil prices contributing to inflation concerns.

30 de jul. de 2026, 22:01 UTC

Novavax Inc. shares advanced in after-market trading, rebounding from earlier session lows, though they remain below the 20-day moving average.

29 de jul. de 2026, 23:06 UTC

Novavax Inc. shares are higher in after-market trading, gaining slightly since Wednesday's close, despite broader market weakness and significant declines over the past month.

28 de jul. de 2026, 16:06 UTC

Novavax Inc. shares are lower today, reflecting broader market declines amid investor caution ahead of earnings and the Federal Reserve's interest rate decision.

27 de jul. de 2026, 14:02 UTC

Novavax Inc shares are higher in pre-market trading, rising to $7.73. This increase occurs amid three consecutive lower session closes and mixed economic data.

24 de jul. de 2026, 18:46 UTC

Novavax Inc. shares are lower today, continuing a trend of declines following three consecutive sessions of lower closes and trading below the 20-day moving average.

23 de jul. de 2026, 09:01 UTC

Novavax Inc shares are higher in pre-market trading, reflecting upward momentum since Wednesday. Broader market sentiment remains positive amid rising Asian equity indices.

22 de jul. de 2026, 23:11 UTC

Novavax Inc. shares are higher in after-market hours, driven by strength in biotechnology stocks. The company remains below its 20-day moving average.

21 de jul. de 2026, 22:46 UTC

Novavax Inc. shares declined in after-market trading, remaining below their 20-day moving average despite a broader market rebound in the tech sector.

20 de jul. de 2026, 23:46 UTC

Novavax Inc. shares traded roughly flat after-market with no specific news identified. The stock remains significantly below its 20-day moving average.